 Curtis Coughlin II
Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 13 | 2022 | 290 | 3.990 |
Why?
| | Pyridoxine | 8 | 2022 | 26 | 2.190 |
Why?
| | Lysine | 7 | 2022 | 245 | 1.800 |
Why?
| | Hyperglycinemia, Nonketotic | 7 | 2019 | 42 | 1.760 |
Why?
| | Arginine | 4 | 2020 | 241 | 1.400 |
Why?
| | Neonatal Screening | 3 | 2022 | 151 | 1.390 |
Why?
| | Aldehyde Dehydrogenase | 7 | 2022 | 129 | 1.350 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 3 | 2023 | 19 | 1.170 |
Why?
| | Brain Diseases, Metabolic | 2 | 2023 | 7 | 1.070 |
Why?
| | Disclosure | 4 | 2023 | 102 | 0.880 |
Why?
| | Genetic Counseling | 3 | 2023 | 67 | 0.860 |
Why?
| | Lipid Metabolism, Inborn Errors | 2 | 2015 | 16 | 0.840 |
Why?
| | Vitamin B Complex | 2 | 2022 | 37 | 0.690 |
Why?
| | Pipecolic Acids | 2 | 2019 | 22 | 0.680 |
Why?
| | Dietary Supplements | 2 | 2020 | 458 | 0.660 |
Why?
| | Mutation, Missense | 4 | 2016 | 296 | 0.610 |
Why?
| | Infant, Newborn | 17 | 2022 | 5077 | 0.560 |
Why?
| | Glycine Decarboxylase Complex | 1 | 2016 | 5 | 0.550 |
Why?
| | Glycine Dehydrogenase (Decarboxylating) | 1 | 2016 | 6 | 0.550 |
Why?
| | Aminomethyltransferase | 1 | 2016 | 8 | 0.550 |
Why?
| | Seizures | 4 | 2022 | 344 | 0.530 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2015 | 28 | 0.500 |
Why?
| | 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.500 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.500 |
Why?
| | Brain Diseases | 2 | 2020 | 127 | 0.490 |
Why?
| | Genetic Testing | 6 | 2023 | 382 | 0.470 |
Why?
| | Mitochondria | 2 | 2020 | 750 | 0.450 |
Why?
| | DNA, Mitochondrial | 1 | 2015 | 185 | 0.450 |
Why?
| | Neurodevelopmental Disorders | 1 | 2015 | 109 | 0.450 |
Why?
| | Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2010 | 3 | 0.440 |
Why?
| | Sudden Infant Death | 2 | 2010 | 24 | 0.430 |
Why?
| | Hyperargininemia | 2 | 2018 | 2 | 0.420 |
Why?
| | Chromosomes, Human, Pair 16 | 2 | 2021 | 30 | 0.420 |
Why?
| | Humans | 50 | 2023 | 115587 | 0.410 |
Why?
| | Glutaryl-CoA Dehydrogenase | 2 | 2023 | 4 | 0.410 |
Why?
| | Amino Acids | 1 | 2015 | 454 | 0.390 |
Why?
| | Glycine | 3 | 2017 | 156 | 0.380 |
Why?
| | Mutation | 8 | 2020 | 3364 | 0.380 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2010 | 3 | 0.360 |
Why?
| | Urinary Tract | 1 | 2010 | 37 | 0.360 |
Why?
| | Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2010 | 7 | 0.360 |
Why?
| | Sequence Deletion | 1 | 2010 | 167 | 0.350 |
Why?
| | Energy Metabolism | 1 | 2015 | 715 | 0.340 |
Why?
| | Mosaicism | 1 | 2010 | 60 | 0.340 |
Why?
| | Primary Health Care | 1 | 2019 | 1518 | 0.340 |
Why?
| | Mitochondrial Diseases | 1 | 2010 | 77 | 0.330 |
Why?
| | Muscular Diseases | 1 | 2010 | 104 | 0.330 |
Why?
| | Hirschsprung Disease | 1 | 2010 | 87 | 0.330 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1310 | 0.320 |
Why?
| | Diet Therapy | 2 | 2020 | 36 | 0.310 |
Why?
| | DNA Mutational Analysis | 4 | 2015 | 372 | 0.300 |
Why?
| | Infant | 16 | 2022 | 7979 | 0.290 |
Why?
| | Liver | 3 | 2023 | 1690 | 0.280 |
Why?
| | Hypoglycemia | 2 | 2010 | 386 | 0.270 |
Why?
| | Male | 26 | 2020 | 55949 | 0.270 |
Why?
| | Cognition | 3 | 2022 | 980 | 0.260 |
Why?
| | Arginase | 1 | 2015 | 27 | 0.260 |
Why?
| | Genetic Variation | 2 | 2015 | 877 | 0.260 |
Why?
| | Genetic Diseases, X-Linked | 2 | 2017 | 22 | 0.250 |
Why?
| | Genetic Diseases, Inborn | 1 | 2015 | 37 | 0.250 |
Why?
| | Heterozygote | 4 | 2020 | 252 | 0.240 |
Why?
| | Databases, Genetic | 1 | 2015 | 208 | 0.230 |
Why?
| | Child, Preschool | 14 | 2022 | 9133 | 0.230 |
Why?
| | Kidney | 1 | 2010 | 1207 | 0.220 |
Why?
| | Glutarates | 1 | 2023 | 6 | 0.220 |
Why?
| | Phenotype | 6 | 2020 | 2829 | 0.220 |
Why?
| | Counselors | 1 | 2023 | 11 | 0.220 |
Why?
| | Acidosis, Lactic | 3 | 2020 | 29 | 0.220 |
Why?
| | Genome, Human | 1 | 2015 | 352 | 0.220 |
Why?
| | Leigh Disease | 2 | 2020 | 17 | 0.210 |
Why?
| | Genotype | 2 | 2019 | 1786 | 0.210 |
Why?
| | Gene Expression | 2 | 2020 | 1435 | 0.210 |
Why?
| | Hyperammonemia | 2 | 2016 | 15 | 0.200 |
Why?
| | Urea Cycle Disorders, Inborn | 2 | 2019 | 22 | 0.200 |
Why?
| | Genetic Predisposition to Disease | 3 | 2015 | 2125 | 0.200 |
Why?
| | Intellectual Disability | 2 | 2021 | 129 | 0.200 |
Why?
| | Child | 16 | 2021 | 18488 | 0.200 |
Why?
| | 2-Aminoadipic Acid | 2 | 2019 | 7 | 0.190 |
Why?
| | Metabolism | 1 | 2021 | 36 | 0.190 |
Why?
| | Female | 23 | 2022 | 59913 | 0.190 |
Why?
| | Motor Disorders | 1 | 2021 | 16 | 0.190 |
Why?
| | Genomic Structural Variation | 1 | 2021 | 7 | 0.190 |
Why?
| | Segmental Duplications, Genomic | 1 | 2021 | 7 | 0.190 |
Why?
| | Metabolism, Inborn Errors | 1 | 2021 | 39 | 0.190 |
Why?
| | Williams Syndrome | 1 | 2021 | 15 | 0.190 |
Why?
| | Chromosome Disorders | 1 | 2021 | 34 | 0.180 |
Why?
| | Craniofacial Abnormalities | 1 | 2021 | 59 | 0.180 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 11 | 0.180 |
Why?
| | Quinone Reductases | 1 | 2020 | 15 | 0.180 |
Why?
| | Anticonvulsants | 1 | 2022 | 181 | 0.180 |
Why?
| | International Cooperation | 1 | 2020 | 174 | 0.170 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2020 | 97 | 0.170 |
Why?
| | 22q11 Deletion Syndrome | 1 | 2019 | 2 | 0.170 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 40 | 0.170 |
Why?
| | Biomarkers | 3 | 2019 | 3466 | 0.170 |
Why?
| | Orphan Drug Production | 1 | 2019 | 6 | 0.170 |
Why?
| | Tryptophan | 1 | 2020 | 136 | 0.170 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 2019 | 39 | 0.170 |
Why?
| | Dietary Proteins | 1 | 2020 | 123 | 0.170 |
Why?
| | Receptors, GABA-A | 1 | 2020 | 88 | 0.170 |
Why?
| | Disabled Persons | 1 | 2021 | 135 | 0.170 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2019 | 104 | 0.170 |
Why?
| | Protein Subunits | 1 | 2020 | 204 | 0.160 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2020 | 133 | 0.160 |
Why?
| | Magnetic Resonance Imaging | 4 | 2020 | 3069 | 0.160 |
Why?
| | Fatal Outcome | 4 | 2016 | 286 | 0.160 |
Why?
| | Corpus Callosum | 1 | 2019 | 57 | 0.160 |
Why?
| | Rare Diseases | 1 | 2019 | 89 | 0.160 |
Why?
| | Chromosome Mapping | 1 | 2019 | 489 | 0.160 |
Why?
| | Consensus | 1 | 2020 | 532 | 0.160 |
Why?
| | Argininosuccinic Aciduria | 1 | 2018 | 2 | 0.160 |
Why?
| | Citrullinemia | 1 | 2018 | 2 | 0.150 |
Why?
| | Communication | 2 | 2021 | 750 | 0.150 |
Why?
| | Bariatric Surgery | 1 | 2020 | 162 | 0.150 |
Why?
| | Alleles | 2 | 2020 | 794 | 0.150 |
Why?
| | White Matter | 1 | 2019 | 103 | 0.150 |
Why?
| | Amino Acid Sequence | 3 | 2020 | 2000 | 0.150 |
Why?
| | Obesity, Morbid | 1 | 2020 | 199 | 0.150 |
Why?
| | Chromatography, Liquid | 1 | 2019 | 347 | 0.140 |
Why?
| | Orotidine-5'-Phosphate Decarboxylase | 1 | 2017 | 1 | 0.140 |
Why?
| | Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 2017 | 2 | 0.140 |
Why?
| | Orotate Phosphoribosyltransferase | 1 | 2017 | 2 | 0.140 |
Why?
| | Infant Nutrition Disorders | 1 | 2017 | 11 | 0.140 |
Why?
| | Cohort Studies | 3 | 2022 | 4944 | 0.140 |
Why?
| | NADH Dehydrogenase | 1 | 2017 | 18 | 0.140 |
Why?
| | Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2016 | 6 | 0.140 |
Why?
| | Methylmalonic Acid | 1 | 2017 | 58 | 0.140 |
Why?
| | Multienzyme Complexes | 1 | 2017 | 64 | 0.140 |
Why?
| | Electron Transport Complex I | 1 | 2017 | 33 | 0.140 |
Why?
| | Point Mutation | 1 | 2017 | 217 | 0.140 |
Why?
| | Dihydrolipoamide Dehydrogenase | 1 | 2016 | 7 | 0.140 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2017 | 74 | 0.140 |
Why?
| | Zebrafish | 1 | 2020 | 412 | 0.140 |
Why?
| | Sodium Benzoate | 1 | 2016 | 5 | 0.130 |
Why?
| | Vascular Malformations | 1 | 2016 | 47 | 0.130 |
Why?
| | Portal Vein | 1 | 2016 | 81 | 0.130 |
Why?
| | Dextromethorphan | 1 | 2016 | 19 | 0.130 |
Why?
| | Informed Consent | 3 | 2023 | 161 | 0.130 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2016 | 89 | 0.130 |
Why?
| | Acyl Coenzyme A | 1 | 2015 | 29 | 0.130 |
Why?
| | Introns | 1 | 2016 | 226 | 0.130 |
Why?
| | Exons | 1 | 2016 | 300 | 0.130 |
Why?
| | Aminoacylation | 1 | 2015 | 12 | 0.130 |
Why?
| | Motor Activity | 1 | 2020 | 633 | 0.130 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1405 | 0.130 |
Why?
| | Dyskinesias | 1 | 2015 | 11 | 0.120 |
Why?
| | Mental Retardation, X-Linked | 1 | 2015 | 13 | 0.120 |
Why?
| | Homocystinuria | 1 | 2015 | 62 | 0.120 |
Why?
| | Cell Respiration | 1 | 2015 | 74 | 0.120 |
Why?
| | Cerebrospinal Fluid | 1 | 2015 | 88 | 0.120 |
Why?
| | Siblings | 1 | 2016 | 223 | 0.120 |
Why?
| | Electron Transport | 1 | 2015 | 112 | 0.120 |
Why?
| | Time-to-Treatment | 1 | 2016 | 147 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2021 | 659 | 0.120 |
Why?
| | Sequence Alignment | 1 | 2015 | 327 | 0.120 |
Why?
| | RNA, Transfer | 1 | 2015 | 119 | 0.120 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 81 | 0.120 |
Why?
| | Sulfurtransferases | 1 | 2013 | 9 | 0.120 |
Why?
| | Glutaredoxins | 1 | 2013 | 11 | 0.120 |
Why?
| | Exome | 1 | 2015 | 202 | 0.110 |
Why?
| | Genetic Association Studies | 2 | 2020 | 343 | 0.110 |
Why?
| | Genes, X-Linked | 1 | 2013 | 17 | 0.110 |
Why?
| | Host Cell Factor C1 | 1 | 2013 | 13 | 0.110 |
Why?
| | Muscles | 1 | 2015 | 326 | 0.110 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 24 | 0.110 |
Why?
| | Cardiomyopathies | 1 | 2017 | 303 | 0.110 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 2790 | 0.110 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2012 | 5 | 0.110 |
Why?
| | Vitamin B 12 | 1 | 2013 | 115 | 0.110 |
Why?
| | Osteoporosis | 1 | 2015 | 227 | 0.110 |
Why?
| | Health Personnel | 1 | 2018 | 581 | 0.100 |
Why?
| | Pediatrics | 1 | 2020 | 986 | 0.100 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2012 | 85 | 0.100 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 962 | 0.100 |
Why?
| | Bone Density | 1 | 2015 | 432 | 0.100 |
Why?
| | Brain | 3 | 2017 | 2370 | 0.100 |
Why?
| | Child Development | 1 | 2016 | 389 | 0.100 |
Why?
| | Ear | 1 | 2010 | 32 | 0.090 |
Why?
| | Adolescent | 7 | 2021 | 17889 | 0.090 |
Why?
| | Chromosomes, Human, X | 1 | 2010 | 60 | 0.090 |
Why?
| | Retrospective Studies | 5 | 2022 | 12608 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 926 | 0.080 |
Why?
| | Cerebral Cortex | 1 | 2012 | 386 | 0.080 |
Why?
| | Amino Acid Substitution | 1 | 2010 | 267 | 0.080 |
Why?
| | Cystinuria | 1 | 2008 | 3 | 0.080 |
Why?
| | Penicillamine | 1 | 2008 | 22 | 0.080 |
Why?
| | Urinary Calculi | 1 | 2008 | 11 | 0.080 |
Why?
| | Longitudinal Studies | 3 | 2018 | 2416 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 746 | 0.080 |
Why?
| | Proteins | 1 | 2013 | 920 | 0.070 |
Why?
| | Tandem Mass Spectrometry | 1 | 2010 | 414 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2114 | 0.070 |
Why?
| | Gene Knockdown Techniques | 2 | 2020 | 302 | 0.070 |
Why?
| | Macaca fascicularis | 1 | 2015 | 51 | 0.060 |
Why?
| | National Library of Medicine (U.S.) | 1 | 2015 | 6 | 0.060 |
Why?
| | Genome-Wide Association Study | 1 | 2010 | 1217 | 0.060 |
Why?
| | United States | 4 | 2020 | 12295 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2010 | 1918 | 0.050 |
Why?
| | Neuropsychological Tests | 2 | 2018 | 919 | 0.050 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1243 | 0.050 |
Why?
| | Chromosome Breakpoints | 1 | 2021 | 6 | 0.050 |
Why?
| | Educational Status | 1 | 2023 | 413 | 0.050 |
Why?
| | Diet, Ketogenic | 1 | 2021 | 33 | 0.050 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2021 | 53 | 0.050 |
Why?
| | Chromosome Deletion | 1 | 2021 | 95 | 0.050 |
Why?
| | Recommended Dietary Allowances | 1 | 2020 | 17 | 0.050 |
Why?
| | Administration, Intravenous | 1 | 2021 | 126 | 0.050 |
Why?
| | Electron Transport Complex IV | 1 | 2020 | 53 | 0.040 |
Why?
| | Vitamins | 1 | 2021 | 151 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 4435 | 0.040 |
Why?
| | Chromosomal Instability | 1 | 2019 | 19 | 0.040 |
Why?
| | Homozygote | 1 | 2020 | 186 | 0.040 |
Why?
| | Locomotion | 1 | 2020 | 81 | 0.040 |
Why?
| | Larva | 1 | 2020 | 193 | 0.040 |
Why?
| | Public-Private Sector Partnerships | 1 | 2019 | 43 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2022 | 352 | 0.040 |
Why?
| | Animals | 4 | 2020 | 32102 | 0.040 |
Why?
| | Young Adult | 3 | 2021 | 10470 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2019 | 107 | 0.040 |
Why?
| | Nutritional Status | 1 | 2021 | 289 | 0.040 |
Why?
| | Spectrum Analysis | 1 | 2019 | 80 | 0.040 |
Why?
| | Primates | 1 | 2019 | 111 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2019 | 310 | 0.040 |
Why?
| | Genetics | 1 | 2018 | 27 | 0.040 |
Why?
| | Drug Industry | 1 | 2019 | 104 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2021 | 240 | 0.040 |
Why?
| | Confidentiality | 1 | 2018 | 67 | 0.040 |
Why?
| | Ammonia | 1 | 2018 | 57 | 0.040 |
Why?
| | Citrulline | 1 | 2018 | 39 | 0.040 |
Why?
| | Glutamine | 1 | 2018 | 91 | 0.040 |
Why?
| | Lipids | 1 | 2021 | 588 | 0.040 |
Why?
| | Orotic Acid | 1 | 2017 | 1 | 0.040 |
Why?
| | Anemia, Megaloblastic | 1 | 2017 | 7 | 0.040 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2017 | 29 | 0.040 |
Why?
| | Uridine | 1 | 2017 | 29 | 0.040 |
Why?
| | Adult | 4 | 2021 | 30718 | 0.040 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2016 | 33 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 924 | 0.040 |
Why?
| | Autopsy | 1 | 2016 | 86 | 0.030 |
Why?
| | Kinetics | 1 | 2020 | 1569 | 0.030 |
Why?
| | Risk Factors | 1 | 2010 | 8697 | 0.030 |
Why?
| | Family | 1 | 2020 | 594 | 0.030 |
Why?
| | Glucose | 1 | 2021 | 904 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2015 | 4773 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2015 | 3580 | 0.030 |
Why?
| | Weight Loss | 1 | 2020 | 633 | 0.030 |
Why?
| | Intelligence Tests | 1 | 2016 | 59 | 0.030 |
Why?
| | Language | 1 | 2018 | 258 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2019 | 440 | 0.030 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2015 | 9 | 0.030 |
Why?
| | Delayed Diagnosis | 1 | 2016 | 71 | 0.030 |
Why?
| | Homocysteine | 1 | 2015 | 135 | 0.030 |
Why?
| | COS Cells | 1 | 2015 | 175 | 0.030 |
Why?
| | Methionine | 1 | 2015 | 145 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 221 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2016 | 220 | 0.030 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 327 | 0.030 |
Why?
| | Pyrimidines | 1 | 2017 | 376 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2651 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2015 | 217 | 0.030 |
Why?
| | Students | 1 | 2018 | 502 | 0.030 |
Why?
| | Atrophy | 1 | 2013 | 152 | 0.030 |
Why?
| | Molybdoferredoxin | 1 | 2012 | 12 | 0.030 |
Why?
| | Mental Disorders | 1 | 2021 | 902 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1357 | 0.030 |
Why?
| | Age of Onset | 1 | 2013 | 450 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 219 | 0.020 |
Why?
| | Decision Making | 1 | 2018 | 791 | 0.020 |
Why?
| | Clinical Competence | 1 | 2018 | 912 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 544 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 602 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1805 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2013 | 369 | 0.020 |
Why?
| | Binding Sites | 1 | 2013 | 1177 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2010 | 50 | 0.020 |
Why?
| | Mice | 1 | 2015 | 15052 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 6264 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4665 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 1917 | 0.020 |
Why?
| | Prognosis | 1 | 2015 | 3339 | 0.020 |
Why?
| | Middle Aged | 2 | 2018 | 26999 | 0.020 |
Why?
| | Colorado | 1 | 2016 | 4113 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2578 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2574 | 0.020 |
Why?
| | Diet | 1 | 2012 | 1072 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2353 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2009 | 2392 | 0.010 |
Why?
|
|
Coughlin II's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|